Charles River Labs Intl buy UBS Group AG
Start price
08.08.24
/
50%
€184.90
Target price
08.08.25
€220.15
Performance (%)
-31.34%
End price
09.08.25
€126.95
Summary
This prediction ended on 09.08.25 with a price of €126.95. The BUY prediction by UBS_Group_AG for Charles River Labs Intl performed very badly with a performance of -31.34%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Charles River Labs Intl | -0.263% | -0.263% | 18.932% |
| iShares Core DAX® | 0.191% | 4.771% | 20.559% |
| iShares Nasdaq 100 | -0.614% | 3.137% | 5.816% |
| iShares Nikkei 225® | 0.599% | 8.016% | 21.913% |
| iShares S&P 500 | -0.036% | 3.593% | 3.588% |
Comments by UBS_Group_AG for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target lowered by analysts at UBS Group AG from $290.00 to $240.00. They now have a "buy" rating on the stock.
Ratings data for CRL provided by MarketBeat
In the thread Trading Charles River Labs Intl
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€195.30
07.11.24
07.11.24
€231.75
07.11.25
07.11.25
-25.40%
08.11.25
08.11.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€269.47
15.02.25
15.02.25
-36.02%
16.02.25
16.02.25
Charles River Labs Intl
Start price
Target price
Perf. (%)
€158.95
09.11.23
09.11.23
€201.48
09.11.24
09.11.24
26.14%
10.11.24
10.11.24